Buy Cadila Healthcare: target of Rs 720: Sharekhan
Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 27, 2021.
June 10, 2021 / 11:37 AM IST
Sharekhan's research report on Cadila Healthcare
Cadila Healthcare’s (Cadila) Q4FY2021 numbers were healthy and earnings beat estimates, due to a tax credit and an adjustment for a one-time impairment expenses. Cadila is in a sweet spot, wherein both its geographies, India and the US have an improved growth outlook. Efforts to build a portfolio of Covid drugs including Vaccines augurs well from a growth perspective.
We retain our Buy recommendation on the stock with unchanged PT of Rs. 720
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.